Display options
Cite
Barasch A, Epstein J, Tilashalski K. Palifermin for management of treatment-induced oral mucositis in cancer patients. Biologics. 2009;3:111-6doi: 10.2147/btt.2009.2871.
Barasch, A., Epstein, J., & Tilashalski, K. (2009). Palifermin for management of treatment-induced oral mucositis in cancer patients. Biologics : targets & therapy, 3111-6. https://doi.org/10.2147/btt.2009.2871
Barasch, Andrei, et al. "Palifermin for management of treatment-induced oral mucositis in cancer patients." Biologics : targets & therapy vol. 3 (2009): 111-6. doi: https://doi.org/10.2147/btt.2009.2871
Barasch A, Epstein J, Tilashalski K. Palifermin for management of treatment-induced oral mucositis in cancer patients. Biologics. 2009;3:111-6. doi: 10.2147/btt.2009.2871. Epub 2009 Jul 13. PMID: 19707400; PMCID: PMC2726051.
Copy Download .nbib Format: NLM
Share it on

Biologics. 2009;3:111-6. doi: 10.2147/btt.2009.2871. Epub 2009 Jul 13.

Palifermin for management of treatment-induced oral mucositis in cancer patients.

Biologics : targets & therapy

Andrei Barasch, Joel Epstein, Ken Tilashalski

Affiliations

  1. Department of Diagnostic Sciences, University of Alabama at Birmingham, Birmingham, AL, USA. [email protected]

PMID: 19707400 PMCID: PMC2726051 DOI: 10.2147/btt.2009.2871

Abstract

Oral mucositis (OM) remains a major side effect of various cancer therapies, which exacts a significant price in terms of morbidity and cost of care. Efforts aimed at prevention and/or therapy of OM have been largely unsuccessful. Few agents have shown efficacy, and even those were applicable to limited types of patients. The advent of small-molecule targeted agents opened new possibilities for intervention in the mucopathogenic processes induced by cancer therapies. One of these agents, recombinant human keratinocyte growth factor (KGF), has been studied extensively and has shown promising results in reducing chemotherapy induced OM. This drug's effects on stem cell engraftment, graft-versus-host disease and other treatment-induced morbidities remain undefined. In this article we evaluate the pre-clinical and clinical evidence and discuss the clinical applications of KGF as an adjunct therapeutic agent in oncology.

Keywords: cancer; mucositis; palifermin; therapy

References

  1. Nat Rev Cancer. 2004 Apr;4(4):277-84 - PubMed
  2. Bone Marrow Transplant. 2007 Nov;40(10):983-8 - PubMed
  3. Cell Prolif. 2002 Aug;35 Suppl 1:86-92 - PubMed
  4. J Clin Endocrinol Metab. 2003 Feb;88(2):773-80 - PubMed
  5. N Engl J Med. 2004 Dec 16;351(25):2590-8 - PubMed
  6. Curr Pharm Des. 2002;8(5):395-403 - PubMed
  7. J Clin Oncol. 2001 Apr 15;19(8):2201-5 - PubMed
  8. Cancer Chemother Pharmacol. 2002 Sep;50(3):202-12 - PubMed
  9. J Clin Oncol. 2008 May 20;26(15):2489-96 - PubMed
  10. Anticancer Res. 2002 Sep-Oct;22(5):2539-45 - PubMed
  11. Cancer Res. 1998 Mar 1;58(5):933-9 - PubMed
  12. Bone Marrow Transplant. 2008 Aug;42(4):275-9 - PubMed
  13. Biol Blood Marrow Transplant. 2008 Sep;14(9):1017-1021 - PubMed
  14. Cell Prolif. 2002 Aug;35 Suppl 1:78-85 - PubMed
  15. J Clin Oncol. 2003 Apr 15;21(8):1452-8 - PubMed
  16. Support Care Cancer. 2008 May;16(5):477-83 - PubMed
  17. Cell Prolif. 2002 Aug;35 Suppl 1:32-47 - PubMed
  18. Int J Radiat Biol. 2001 Mar;77(3):341-7 - PubMed
  19. Mol Cancer Res. 2008 Aug;6(8):1337-46 - PubMed
  20. Cell Biol Int. 1995 May;19(5):399-411 - PubMed
  21. Cancer Chemother Pharmacol. 2002 Jul;50(1):53-8 - PubMed
  22. J Clin Oncol. 2006 Nov 20;24(33):5194-200 - PubMed
  23. Support Cancer Ther. 2004 Jul 1;1(4):219-29 - PubMed
  24. Oral Oncol. 2003 Feb;39(2):91-100 - PubMed
  25. Blood. 2007 Jul 1;110(1):441-9 - PubMed
  26. Int J Radiat Biol. 1999 May;75(5):609-20 - PubMed
  27. PLoS One. 2008 Jun 25;3(6):e2528 - PubMed
  28. Stem Cells. 2008 Oct;26(10):2595-601 - PubMed
  29. Clin Cancer Res. 2004 Dec 15;10(24):8318-24 - PubMed
  30. Biol Blood Marrow Transplant. 2007 Jul;13(7):806-13 - PubMed
  31. Blood. 2000 Dec 15;96(13):4350-6 - PubMed
  32. Ann Oncol. 2008 Sep;19(9):1644-9 - PubMed
  33. Eur J Oral Sci. 2003 Feb;111(1):42-50 - PubMed
  34. Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):177-87 - PubMed
  35. Support Care Cancer. 2007 Jan;15(1):105-9 - PubMed
  36. Clin Cancer Res. 2003 Aug 15;9(9):3454-61 - PubMed
  37. Pharmacol Res. 2002 Aug;46(2):179-83 - PubMed
  38. Gene Ther. 2002 Aug;9(16):1065-74 - PubMed
  39. Support Cancer Ther. 2005 Jan 1;2(2):122-7 - PubMed

Publication Types